Trials / Completed
CompletedNCT05041231
Effects of Using Custom Photobiomodulation Therapy for the Treatment of Osteoarthritis of the Fingers and Rhizarthrosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Vita Care · Academic / Other
- Sex
- All
- Age
- 40 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Osteoarthrosis (OA), a multifactorial degenerative process, is responsible for joint pain and functional limitation. In the hand, more specifically in the proximal and distal interphalangeal joints of the fingers, it is one of the sites of greatest manifestation of the disease. Numerous treatments, whether drug, rehabilitation or surgery, have been proposed with the aim of both interrupting the natural evolution of the disease and alleviating or stopping the symptoms. This study aims to evaluate the effectiveness of personalized Photobiomodulation Therapy (PBT) with regard to alleviating symptoms and improving the quality of life of these patients with the disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Photobiomodulation therapy (PBT) | Any invasive procedures will be done. The treatment in question will be done by a device that looks like a bracelet, which is placed on the hand/fingers to emit light/laser and does not cause pain or temperature change. There will be 8 photobiomodulation sessions, 2 per week, 10 minutes each session. The dosimetric parameters of the therapy will be carried out in a standardized and personalized way, with programming of the light and all the necessary information so that the device can carry out the application of the treatment application of electromagnetic waves in the red and infrared spectral range 660-1000 nm). |
| DEVICE | Sham Photobiomodulation therapy (Sham PBT) | Similar to active PBT, however, the device will not provide the active electromagnetic waves) |
Timeline
- Start date
- 2021-08-25
- Primary completion
- 2022-12-31
- Completion
- 2023-01-20
- First posted
- 2021-09-10
- Last updated
- 2023-01-23
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05041231. Inclusion in this directory is not an endorsement.